StonvexLoading…
StonvexStonvexStonvexCore line items from DBX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.52B | $2.55B | $2.50B | $2.32B |
Operating Income | $689.10M | $486.20M | $538.70M | $181.30M |
Net Income | $508.40M | $452.30M | $453.60M | $553.20M |
EPS (Diluted) | $1.86 | $1.40 | $1.31 | $1.52 |
Total Assets | $2.84B | $3.33B | $2.98B | $3.11B |
Total Liabilities | $4.64B | $4.08B | $3.15B | $3.42B |
Cash & Equivalents | $891.30M | $1.33B | $614.90M | $232.80M |
Free Cash Flow OCF − CapEx | $930.80M | $871.60M | $759.40M | $763.50M |
Shares Outstanding | 272.80M | 323.40M | 345.60M | 363.30M |